Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended ... - MarketWatch (press release)
Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended .
Actavis receives FDA approval for Ropinirole ER Tablets - News-Medical.net
Actavis receives FDA approval for Ropinirole ER TabletsNews-Medical.
NuPathe Announces First Quarter 2012 Financial Results and Operational Highlights - MarketWatch (press release)
NuPathe Announces First Quarter 2012 Financial Results and Operational HighlightsMarketWatch (press release)NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery.
Safeguard Scientifics Announces First Quarter 2012 Financial ResultsMarketWatch (press release)NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery.
아닌 밤중 '움찔움찔' 이유 있는 불면 - 충청투데이
충청투데이아닌 밤중 '움찔움찔' 이유 있는 불면충청투데이대표적인 약물치료로는 도파민 전구물질제 투여와 도파민수용체효현제인 로피니롤(Ropinirole), 프라미펙솔(Pramipexole), 벤조디아제핀계약인 클로나제팜, 항경련제인 가바펜틴 등의 약을 사용한다.
us